Erythromycin
Sold as Erythromycin s biotech, Erythromycin PHARMC, A-lennon erythromycin es, Erystat, Xeramel s, Xeramel sf, Lilly-erythromycin 250p, Lilly-erythromycin 125p, Etocin, Eryko, Racemin, Ilosone p, Ilosone, Erythrocin I.V., Erythroped neo, Erythromid, Erythrocin*, Ethimycin, Erythrocin, Infectocin, Adco-erythromycin, Spectrasone c, Spectrasone s, Purmycin, Rubimycin, Ilotycin T.S., Eryderm, Erymycin af, Erymax, Erythroped a, Erymax paediatric sprinkle, Adco erythromycin, Spectrasone sf, Rubimycin eye, Succin, Erymycin estolate p, Erymycin estolate pf, Betamycin, Ryped
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 18
- Registrations
- 45
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Biotech Laboratories (Pty) Ltd | Erythromycin s biotech | 125 | 270329 | S4 | None |
| Pharmacorp (Pty) Ltd | Erythromycin PHARMC | 125mg/5ml | 270450 | S4 | None |
| Pharmacare limited û woodmead9 of 12 cancelled | A-lennon erythromycin es, Lilly-erythromycin 250p, Lilly-erythromycin 125p, Ilosone, Ethimycin, Infectocin, Rubimycin, Ilotycin T.S., Rubimycin eye | 250 mg/5 ml, 250 mg -, 250, 500, ointment | 280062, 280190, 290639, 300276, A0118, B0167, E0085, G0195, M0068, M0069, M0080, W0447 | S4 | None |
| Medpro Pharmaceutica (Pty) Ltd | Erystat | Not stated | 280118 | S4 | None |
| FDC SA (Pty) Ltd | Xeramel s, Xeramel sf | Not stated | 280387, 280388 | S4 | None |
| Unimed Healthcare (Pty) Ltd | Etocin | 250 mg | 360221 | S4 | None |
| Dezzo Trading 392 (Pty) Ltd | Eryko | 250 | 360222 | S4 | None |
| Gulf Drug Company (Pty) Ltd | Racemin | 250 | 410976 | S4 | None |
| Quatromed limited | Ilosone p | 125 | A0117 | S4 | None |
| Pharmaco Distribution (Pty) Ltd4 of 6 cancelled | Erythrocin I.V., Erythroped neo, Erythromid, Erythrocin, Eryderm, Erythroped a | 500 | A0568, A0813, C0097, F0109, Q0248, R0143 | S4 | None |
| Abbott Laboratories S.A. (Pty) Ltd | Erythrocin*, Succin | suppository | C0098, X0101 | S4 | None |
| Adcock ingram limited2 of 6 cancelled | Adco-erythromycin, Purmycin, Adco erythromycin | 125 mg/5 ml, capsules, 125, 250, 500 | J0115, L0145, L0148, L0149, V0006, W0448 | S4 | None |
| Arya Pharma (Pty) Ltd | Spectrasone c | 250 | L0092 | S4 | None |
| Alliance Pharma (Pty) Ltd | Spectrasone s, Spectrasone sf | 125, 250 | L0093, W0402 | S4 | None |
| Acino Pharma (Pty) Ltd2 of 3 cancelled | Erymycin af, Erymycin estolate p, Erymycin estolate pf | Not stated | Q0307, Y0183, Y0184 | S4 | None |
| Warner-lambert SA (Pty) Ltd1 of 2 cancelled | Erymax, Erymax paediatric sprinkle | 125 mg | R0078, V0005 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) Ltd | Betamycin | 125 mg | Z0322 | S4 | None |
| The Premier Pharmaceutical Co Ltd | Ryped | Not stated | Z0394 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Erythromycin 125 s biotech EACH 5 ml SUSPENSION CONTAINS: ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 125 mg | 125 | 27032927/20.1.1/0329 | Registered | S4 | None |
| Erythromycin 125mg/5ml PHARMC EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125 mg ERYTHROMYCIN | 125mg/5ml | 27045027/20.1.1/0450 | Registered | S4 | None |
| A-lennon erythromycin es 250 mg/5 ML EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN. | 250 mg/5 ml | 28006228/20.1.1/0062 | Cancelled | S4 | None |
| Erystat* EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 125 mg | Not listed | 28011828/20.1.1/0118 | Registered | S4 | None |
| A-lennon erythromycin es - 250 MG capsules EACH CAPSULE CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN | 250 mg -Capsules | 28019028/20.1.1/0190 | Cancelled | S4 | None |
| Xeramel s EACH 5 ml CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 125 mg | Not listed | 28038728/20.1.1/0387 | Registered | S4 | None |
| Xeramel sf EACH 5,0 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 250,0 mg | Not listed | 28038828/20.1.1/0388 | Registered | S4 | None |
| Lilly-erythromycin 250p EACH 5 ml CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN | Not listed | 29063929/20.1.1/0639 | Cancelled | S4 | None |
| Lilly-erythromycin 125p EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125,0 mg ERYTHROMYCIN | Not listed | 30027630/20.1.1/0276 | Cancelled | S4 | None |
| Etocin 250 MG EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO ERYTHROMYCIN 250,0 mg | 250 mg | 36022136/20.1.1/0221 | Registered | S4 | None |
| Eryko-250 EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO ERYTHROMYCIN 250,0 mg | 250 | 36022236/20.1.1/0222 | Registered | S4 | None |
| Racemin 250 EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO ERYTHROMYCIN 250,0 mg | 250 | 41097641/20.1.1/0976 | Registered | S4 | None |
| Ilosone 125 p EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125 mg ERYTHROMYCIN | 125 | A0117A/20.1.1/117 | Registered | S4 | None |
| Ilosone 250 EACH CAPSULE CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN | 250 | A0118A/20.1.1/118 | Cancelled | S4 | None |
| Erythrocin I.V. EACH 1,0 ml SOLUTION CONTAINS ERYTHROMYCIN LACTOBIONATE A EQUIVALENT TO ERYTHROMYCIN 50,0 mg | Not listed | A0568 | Old Medicine | S4 | None |
| Erythroped neo EACH 5 ML CONTAINS ERYTHROMYCIN ETHYL SUCCINATE A EQUIVALENT TO 125 mg ERYTHROMYCIN | Not listed | A0813 | Old Medicine | S4 | None |
| Ilosone 500 EACH TABLET CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 500,0 mg ERYTHROMYCIN | 500 | B0167B/20.1.1/167 | Cancelled | S4 | None |
| Erythromid EACH TABLET CONTAINS ERYTHROMYCIN 250 MG | Not listed | C0097C/20.1.1/97 | Cancelled | S4 | None |
| Erythrocin* suppository EACH SUPPOSITORY CONTAINS ERYTHROMYCIN 125 mg | Suppository | C0098C/20.1.1/98 | Registered | S4 | None |
| Ethimycin EACH CAPSULE CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 250 mg ERYTHROMYCIN | Not listed | E0085E/20.1.1/85 | Cancelled | S4 | None |
| Erythrocin 500 EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 500,0 mg ERYTHROMYCIN | 500 | F0109F/20.1.1/109 | Cancelled | S4 | None |
| Infectocin EACH CAPSULE CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 250 mg ERYTHROMYCIN | Not listed | G0195G/20.1.1/195 | Cancelled | S4 | None |
| Adco-erythromycin 125 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125,0 mg ERYTHROMYCIN | 125 mg/5 ml | J0115J/20.1.1/115 | Cancelled | S4 | None |
| Spectrasone c 250 EACH CAPSULE CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN | 250 | L0092L/20.1.1/92 | Registered | S4 | None |
| Spectrasone s 125 EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125,0 mg ERYTHROMYCIN | 125 | L0093L/20.1.1/93 | Registered | S4 | None |
| Purmycin capsules EACH CAPSULE CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 MG ERYTHROMYCIN | Capsules | L0145L/20.1.1/145 | Registered | S4 | None |
| Purmycin - 125 suspension EACH 5 ML SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125 MG ERYTHROMYCIN | - 125Suspension | L0148L/20.1.1/148 | Registered | S4 | None |
| Purmycin - 250 suspension EACH 5 ML SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 MG ERYTHROMYCIN | - 250Suspension | L0149L/20.1.1/149 | Registered | S4 | None |
| Rubimycin - 250 tablets EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 250 mg ERYTHROMYCIN | - 250Tablets | M0068M/20.1.1/68 | Registered | S4 | None |
| Rubimycin - 500 tablets EACH TABLET CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 500 mg ERYTHROMYCIN | - 500Tablets | M0069M/20.1.1/69 | Registered | S4 | None |
| Ilotycin T.S. EACH ml SOLUTION CONTAINS ERYTHROMYCIN 20 mg | Not listed | M0080M/20.1.6/80 | Registered | S4 | None |
| Eryderm EACH 1 ml TOPICAL SOLUTION CONTAINS ERYTHROMYCIN 20 mg | Not listed | Q0248Q/20.1.1/248 | Cancelled | S4 | None |
| Erymycin af EACH CAPSULE CONTAINS : ERYTHROMYCIN STEARATE EQUIVALENT TO ERYTHROMYCIN 250 mg | Not listed | Q0307Q/20.1.1/307 | Registered | S4 | None |
| Erymax* EACH TABLET CONTAINS ERYTHROMYCIN 250 mg | Not listed | R0078R/20.1.1/78 | Registered | S4 | None |
| Erythroped a EACH TABLET CONTAINS ERYTHROMYCIN ETHYL SUCCINATE EQUIVALENT TO ERYTHROMYCIN 400 mg | Not listed | R0143R/20.1.1/143 | Cancelled | S4 | None |
| Erymax paediatric sprinkle 125 mg* EACH CAPSULE CONTAINS ERYTHROMYCIN 125 mg | 125 mg | V0005V/20.1.1/0005 | Cancelled | S4 | None |
| Adco erythromycin capsules EACH CAPSULE CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 250 mg | Capsules | V0006V/20.1.1/6 | Cancelled | S4 | None |
| Spectrasone sf 250 EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 250 mg ERYTHROMYCIN | 250 | W0402W/20.1.1/402 | Registered | S4 | None |
| Rubimycin eye ointment EACH 1 g OINTMENT CONTAINS ERYTHROMYCIN 5 mg | Ointment | W0447W/15.1/447 | Cancelled | S4 | None |
| Purmycin - 500 EACH TABLET CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 500 MG ERYTHROMYCIN | - 500 | W0448W/20.1.1/448 | Registered | S4 | None |
| Succin* EACH TABLET CONTAINS ERYTHROMYCIN ETHYL SUCCINATE EQUIVALENT TO 500,0 mg ERYTHROMYCIN | Not listed | X0101X/20.1.1/101 | Registered | S4 | None |
| Erymycin estolate p EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 125 mg | Not listed | Y0183Y/20.1.1/183 | Cancelled | S4 | None |
| Erymycin estolate pf EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 250 mg | Not listed | Y0184Y/20.1.1/184 | Cancelled | S4 | None |
| Betamycin granules 125 mg* EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125 mg ERYTHROMYCIN | 125 mgGranules | Z0322Z/20.1.1/322 | Registered | S4 | None |
| Ryped EACH 5 ml SUSPENSION CONTAINS ERYTHROMYCIN ESTOLATE EQUIVALENT TO 125 mg ERYTHROMYCIN | Not listed | Z0394Z/20.1.1/394 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Erythromycin estolate equivalent to erythromycin
S4: Erythromycin
Consolidated Schedules 06 July 2026, line 6237
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.